Jeff Yass’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Jeff Yass’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-26,679	Closed	-$105K	–	13768
2023 Q3	$105K	Buy	+26,679	New	+$182K	﹤0.01%	10872
2023 Q2	–	Sell	-9,205	Closed	-$33.3K	–	13589
2023 Q1	$33.3K	Buy	9,205 +1,902	+26%	+$29.4K	﹤0.01%	11871
2022 Q4	$235K	Buy	7,303 +6,404	+712%	+$254K	﹤0.01%	9721
2022 Q3	$38K	Buy	+899	New	+$41.1K	﹤0.01%	12361
2022 Q2	–	Sell	-10,138	Closed	-$470K	–	14362
2022 Q1	$687K	Buy	+10,138	New	+$844K	﹤0.01%	8133
2021 Q2	–	Sell	-1,724	Closed	-$435K	–	13495
2021 Q1	$369K	Buy	+1,724	New	+$477K	﹤0.01%	10165
2020 Q4	–	Sell	-593	Closed	-$62K	–	11921
2020 Q3	$62K	Buy	+593	New	+$54K	﹤0.01%	10142

Other funds holding EVLO

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jeff Yass's EVLO Position: Q4 2023 in Review

Jeff Yass sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 26,679 shares — an estimated $105K sold.

Jeff Yass first reported a position in EVLO in Q3 2020 and held it in 7 quarters. The position peaked at $687K in Q1 2022. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

Jeff Yass reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Jeff Yass sold 26,679 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $105K.
Jeff Yass first reported a position in Evelo Biosciences, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Jeff Yass's Evelo Biosciences, Inc. Common Stock position peaked at $687K in Q1 2022.
2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.